Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

245Citations
Citations of this article
334Readers
Mendeley users who have this article in their library.

Abstract

Despite the progress of the past two decades, the cause of Alzheimer's disease (AD) and effective treatments against it remain elusive. The hypothesis that amyloid-β (Aβ) peptides are the primary causative agents of AD retains significant support among researchers. Nonetheless, a growing body of evidence shows that Aβ peptides are unlikely to be the sole factor in AD etiology. Evidence that Aβ/amyloid-independent factors, including the actions of AD-related genes, also contribute significantly to AD pathogenesis was presented in a symposium at the 2010 Annual Meeting of the Society for Neuroscience. Here we summarize the studies showing how amyloid-independent mechanisms cause defective endo-lysosomal trafficking, altered intracellular signaling cascades, or impaired neurotransmitter release and contribute to synaptic dysfunction and/or neurodegeneration, leading to dementia in AD. A view of AD pathogenesis that encompasses both the amyloid-dependent and -independent mechanisms will help fill the gaps in our knowledge and reconcile the findings that cannot be explained solely by the amyloid hypothesis. Copyright © 2010 the authors.

Cite

CITATION STYLE

APA

Pimplikar, S. W., Nixon, R. A., Robakis, N. K., Shen, J., & Tsai, L. H. (2010). Amyloid-independent mechanisms in Alzheimer’s disease pathogenesis. In Journal of Neuroscience (Vol. 30, pp. 14946–14954). https://doi.org/10.1523/JNEUROSCI.4305-10.2010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free